查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1494624

胃肠道药物市场：按类型、疾病类型、给药途径、分销管道、最终用户分类 - 全球预测 2024-2030

Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of Administration, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年胃肠道药物市场规模为572.6亿美元，预计2024年将达600.6亿美元，2030年将达804.7亿美元，复合年增长率为4.97%。

胃肠道药物是一类旨在治疗影响胃肠道（包括胃和肠道）的各种疾病的药物。这些病症包括胃酸逆流和溃疡、大肠激躁症和克隆氏症。这些药物的主要作用是改善肠道功能、缓解症状以及控製或治疗潜在的胃肠道疾病。随着胃食道逆流、消化性溃疡和发炎性肠道疾病（IBD）等胃肠道疾病在世界各地呈上升趋势，需要有效的胃肠道药物。发展中地区胃肠道健康意识的提高和卫生服务的改善也有助于扩大胃肠道药物的使用。胃肠道药物的高治疗成本和抗药性问题正在阻碍市场成长。胃肠病学的持续研究和开发预计将带来更有效、更安全的药物的推出，为胃肠道药物市场创造机会。

主要市场统计
基准年[2023] 572.6亿美元
预测年份 [2024] 600.6亿美元
预测年份 [2030] 804.7亿美元
复合年增长率（%） 4.97%

区域洞察

美洲地区先进的医疗体系、人们对胃肠道疾病的认知度高以及对医疗保健的高投入，使得胃肠道药物市场得到了极大的开拓。胃肠道疾病的高盛行率和製药公司的强大存在构成了胃肠道药物市场的基础。在南美洲，医疗基础设施的改善和医疗保险覆盖率的扩大正在逐步提振市场。在亚太地区，人口成长、医疗成本上升以及人们对胃肠道疾病的认识不断提高，正在推动胃肠道药物市场的快速成长。日本、中国和印度等国家在这一增长中处于领先地位，因为它们人口众多，中阶不断壮大，并且可以轻鬆获得医疗保健服务。此外，由于饮食向西式转变，亚太地区胃肠道疾病的盛行率正在增加。欧洲是全球胃肠道药物市场的主要地区，拥有先进的医疗体系和较高的胃肠道疾病盛行率。监管支持和大型製药公司的存在也促进了该市场的成长。虽然波湾合作理事会(GCC) 国家因其发达的医疗基础设施而具有较高的市场渗透率，但非洲其他地区是新兴市场，获得医疗服务的机会有限。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在胃肠道药物市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对胃肠道药物市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前胃肠道药物市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球胃肠道疾病盛行率增加
      • 关于胃肠道健康和可用治疗方法的教育宣传活动
      • 健康保险范围和报销政策的有利变化
    • 抑制因素
      • 药品生产所需原料供应中断
    • 机会
      • 政府核准治疗胃肠道疾病的新药
      • 持续研究并开发创新药物配方和输送系统
    • 任务
      • 与胃肠道药物和补充品相关的副作用
  • 市场区隔分析
    • 类型：随着越来越注重健康的消费者的增加，营养食品的使用也增加。
    • 最终用户：作为初始患者治疗和持续管理计划的一部分，医院和诊所胃肠道药物的巨大潜力
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章胃肠道药物市场：按类型

  • 膳食食品
  • 药品

第七章胃肠道药物市场：依疾病类型

  • 便秘
  • 腹泻
  • 胃食道逆流症
  • 发炎性肠道疾病
  • 大肠激躁症
  • 消化性溃疡

第八章胃肠道药物市场：依给药途径分类

  • 口服
  • 胃肠外的
  • 直肠

第九章胃肠道药物市场：依分销管道划分

  • 线下药局
  • 网路药房

第十章胃肠道药物市场：依最终使用者分类

  • 居家护理
  • 医院/诊所

第十一章 北美洲和南美胃肠道药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太胃肠道药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲胃肠道药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Calm & Focus 简介：PLT Health Solutions 基于 Zembrin 和 GABA 的膳食食品
    • Designs for Health 推出有益于女性健康的创新益生菌
    • 在 Target 商店推出 Wonder Berry 限量口味制酸剂
  • 战略分析和建议

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-CB04E056533F

[195 Pages Report] The Gastrointestinal Agents Market size was estimated at USD 57.26 billion in 2023 and expected to reach USD 60.06 billion in 2024, at a CAGR 4.97% to reach USD 80.47 billion by 2030.

Gastrointestinal agents are a category of medications designed to treat various conditions that affect the gastrointestinal tract, which includes the stomach and intestines. These conditions range from acid reflux and ulcers to irritable bowel syndrome and Crohn's disease. The primary role of these agents is to improve gut function, relieve symptoms, and manage or cure underlying GI disorders. The rise in gastrointestinal diseases around the world, including conditions such as gastroesophageal reflux disease, peptic ulcers, and inflammatory bowel disease (IBD), drives the need for effective gastrointestinal agents. Growing awareness about gastrointestinal health and improved access to healthcare services in developing regions also contribute to the expanded use of GI agents. High treatment costs and drug resistance issues with gastrointestinal agents hamper the market growth. Ongoing research and development in gastroenterology led to introduction of more effective and safer drugs, which are expected to create opportunities for gastrointestinal agent market.

KEY MARKET STATISTICS
Base Year [2023] USD 57.26 billion
Estimated Year [2024] USD 60.06 billion
Forecast Year [2030] USD 80.47 billion
CAGR (%) 4.97%

Regional Insights

In the Americas, the gastrointestinal agents market is highly developing due to advanced healthcare systems, high awareness of gastrointestinal disorders, and substantial investments in healthcare. The higher prevalence of gastrointestinal diseases and the strong presence of pharmaceutical companies create a platform for the gastrointestinal agents market. In South America, improvements in healthcare infrastructure and increased health insurance coverage are gradually boosting the market. The APAC region is seeing rapid growth in the gastrointestinal agents market driven by increasing population, rising healthcare expenditures, and growing awareness of gastrointestinal disorders. Countries such as Japan, China, and India are leading this growth due to their large populations and increasing middle class, which has better access to healthcare services. Additionally, Asia-Pacific is experiencing a shift towards Western diets, increasing the prevalence of gastrointestinal issues. Europe is a major region in the global gastrointestinal agents market, with advanced healthcare systems and a high prevalence of gastrointestinal diseases. Regulatory support and the presence of major pharmaceutical companies also contribute to the growth of this market. The Gulf Cooperation Council (GCC) countries show higher market penetration due to better healthcare infrastructure, while other parts of Africa are emergent markets with limited access to healthcare.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Gastrointestinal Agents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing prevalence of gastrointestinal disorders across the globe
      • Educational campaigns about gastrointestinal health and available treatments
      • Favorable changes in health insurance coverage and reimbursement policies
    • Market Restraints
      • Disruptions in the supply of raw materials required for drug manufacturing
    • Market Opportunities
      • Government approvals for new therapeutic agents to treat gastrointestinal disorders
      • Ongoing research and development aimed at innovative drug formulations and delivery systems
    • Market Challenges
      • Side effects associated with gastrointestinal drugs and supplements
  • Market Segmentation Analysis
    • Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
    • End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Gastrointestinal Agents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Gastrointestinal Agents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions

PLT Health Solutions, in collaboration with Now, has launched 'Calm & Focus with Zembrin & GABA', a new dietary supplement formulated for cognitive enhancement. This product incorporates Zembrin, a patented extract of the South African plant Sceletium tortuosum, traditionally used by the Khoi-San people for mood enhancement and stress reduction. The supplement is designed to offer rapid benefits, promoting alertness, serene focus, and improved mental functionality through the combined effects of Zembrin and GABA, ensuring a balanced approach to stress management and cognitive support. [Published On: 2023-11-17]

Innovative Women's Health Probiotics Launched by Designs for Health

Designs for Health has introduced two new products tailored for women's health across different life stages. The first, ProbioMed Women, is a daily probiotic supplement containing 25 billion CFUs from 10 clinically researched strains. This formulation is engineered to support vaginal pH, microflora balance in the vagina, and gastrointestinal microbial equilibrium. [Published On: 2023-08-17]

Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores

Wonderbelly, an Austin, Texas-based company, is launching its FDA-regulated Wonderbelly Antacid in select Target stores, featuring a Target-exclusive flavor, Fruity Cereal. The product line, designed to alleviate heartburn, acid indigestion, and sour stomach, includes Strawberry Milkshake and Watermelon Mint flavors. This introduction aims to attract customers seeking effective over-the-counter digestive solutions with appealing flavor options. [Published On: 2023-03-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Gastrointestinal Agents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Agents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Health, Amway Corporation, Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, Biomedical Research Laboratories, LLC, DuPont de Nemours, Inc., Dymatize Enterprises LLC, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Himalaya Wellness Company, Nature's Sunshine Products, Inc., Nestle S.A, Nutraceutical International Corporation, NutraScience Labs, Otsuka Holdings Co. Ltd., Pfizer Inc., Pragati Biocare Pvt. Ltd.,, Procter & Gamble Health Limited, Pure Encapsulations, LLC., Sabinsa Corporation, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dietary Supplements
    • Drugs
      • Antacids
      • Anti-diarrheal Agents
      • Anti-emetics
      • H2 Blockers
      • Laxatives
      • Proton Pump Inhibitors
  • Disease Type
    • Constipation
    • Diarrhea
    • Gastroesophageal Reflux Disease
    • Inflammatory Bowel Disease
    • Irritable Bowel Syndrome
    • Peptic Ulcer Disease
  • Route of Administration
    • Oral
    • Parenteral
    • Rectal
  • Distribution Channel
    • Offline Pharmacies
    • Online Pharmacies
  • End-User
    • Homecare
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of gastrointestinal disorders across the globe
      • 5.1.1.2. Educational campaigns about gastrointestinal health and available treatments
      • 5.1.1.3. Favorable changes in health insurance coverage and reimbursement policies
    • 5.1.2. Restraints
      • 5.1.2.1. Disruptions in the supply of raw materials required for drug manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Government approvals for new therapeutic agents to treat gastrointestinal disorders
      • 5.1.3.2. Ongoing research and development aimed at innovative drug formulations and delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with gastrointestinal drugs and supplements
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
    • 5.2.2. End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Gastrointestinal Agents Market, by Type

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. Drugs

7. Gastrointestinal Agents Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Diarrhea
  • 7.4. Gastroesophageal Reflux Disease
  • 7.5. Inflammatory Bowel Disease
  • 7.6. Irritable Bowel Syndrome
  • 7.7. Peptic Ulcer Disease

8. Gastrointestinal Agents Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
  • 8.4. Rectal

9. Gastrointestinal Agents Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Pharmacies
  • 9.3. Online Pharmacies

10. Gastrointestinal Agents Market, by End-User

  • 10.1. Introduction
  • 10.2. Homecare
  • 10.3. Hospitals & Clinics

11. Americas Gastrointestinal Agents Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gastrointestinal Agents Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gastrointestinal Agents Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions
    • 14.3.2. Innovative Women's Health Probiotics Launched by Designs for Health
    • 14.3.3. Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GASTROINTESTINAL AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROINTESTINAL AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GASTROINTESTINAL AGENTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DIST